Key Points
- Insider sale: SOPHiA GENETICS insider Philippe Menu sold 5,000 shares on May 26 at $4.95 each, totaling $24,750. The transaction was made under a pre-arranged Rule 10b5-1 plan, and he still held 250,780 shares afterward.
- Stock and operating update: The shares traded down 1.2% and opened at $4.99, near the stock’s 50-day average of $4.95. SOPHiA GENETICS also reported a quarterly loss of $0.27 per share, missing estimates, though revenue of $21.69 million came in above expectations.
- Analyst and ownership backdrop: Wall Street’s average rating on SOPH is Hold with a $7.50 price target, while institutional investors own about 31.59% of the stock. BTIG Research reiterated a buy rating, while Weiss Ratings maintained a sell rating.
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) insider Philippe Menu sold 5,000 shares of the business's stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $4.95, for a total value of $24,750.00. Following the sale, the insider directly owned 250,780 shares of the company's stock, valued at approximately $1,241,361. This trade represents a 1.95% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Philippe Menu also recently made the following trade(s):
- On Monday, April 27th, Philippe Menu sold 5,000 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.82, for a total value of $24,100.00.
- On Monday, April 20th, Philippe Menu sold 608 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $5.20, for a total value of $3,161.60.
- On Tuesday, April 14th, Philippe Menu sold 1,600 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.96, for a total value of $7,936.00.
- On Monday, April 13th, Philippe Menu sold 4,400 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.76, for a total value of $20,944.00.
- On Friday, April 10th, Philippe Menu sold 3,725 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.68, for a total value of $17,433.00.
- On Thursday, April 9th, Philippe Menu sold 1,931 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.74, for a total value of $9,152.94.
- On Wednesday, April 8th, Philippe Menu sold 2,800 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.84, for a total value of $13,552.00.
- On Tuesday, April 7th, Philippe Menu sold 2,400 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.87, for a total value of $11,688.00.
- On Monday, April 6th, Philippe Menu sold 2,700 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.85, for a total value of $13,095.00.
- On Thursday, March 19th, Philippe Menu sold 608 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.79, for a total value of $2,912.32.
SOPHiA GENETICS Trading Down 1.2%
Shares of SOPH opened at $4.99 on Tuesday. SOPHiA GENETICS SA has a 12 month low of $2.59 and a 12 month high of $5.70. The stock's 50-day moving average is $4.95 and its two-hundred day moving average is $4.84. The company has a debt-to-equity ratio of 1.05, a current ratio of 2.06 and a quick ratio of 1.90. The stock has a market cap of $341.77 million, a PE ratio of -9.60 and a beta of 0.98.
SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.23) by ($0.04). SOPHiA GENETICS had a negative return on equity of 62.74% and a negative net margin of 44.48%.The company had revenue of $21.69 million during the quarter, compared to analysts' expectations of $20.40 million.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of SOPH. First Dallas Securities Inc. acquired a new stake in SOPHiA GENETICS during the first quarter valued at approximately $50,000. Savvy Advisors Inc. acquired a new stake in SOPHiA GENETICS during the third quarter valued at approximately $48,000. Squarepoint Ops LLC acquired a new stake in SOPHiA GENETICS during the third quarter valued at approximately $49,000. Perkins Capital Management Inc. acquired a new stake in SOPHiA GENETICS during the fourth quarter valued at approximately $49,000. Finally, Quadrature Capital Ltd acquired a new stake in SOPHiA GENETICS during the fourth quarter valued at approximately $54,000. Institutional investors and hedge funds own 31.59% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on the company. BTIG Research reaffirmed a "buy" rating and issued a $8.00 target price on shares of SOPHiA GENETICS in a research report on Wednesday, May 6th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of SOPHiA GENETICS in a research report on Tuesday, April 21st. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, SOPHiA GENETICS currently has an average rating of "Hold" and an average price target of $7.50.
Get Our Latest Stock Report on SOPH
SOPHiA GENETICS Company Profile
(
Get Free Report)
SOPHiA GENETICS SA is a data-driven medicine company founded in 2011 and headquartered in La Tène, Switzerland. The firm develops and operates a cloud-native software platform designed to standardize and analyze complex genomic and radiomic data. Its core offering, the SOPHiA DDM™ platform, leverages artificial intelligence and machine learning algorithms to help healthcare institutions, laboratories and biopharmaceutical partners derive actionable insights from next-generation sequencing and medical imaging datasets.
The SOPHiA DDM™ platform supports a range of clinical applications, including oncology, hereditary diseases and rare genetic disorders.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
